Partnervest Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$257K Buy
4,257
+301
+8% +$18.1K 0.08% 192
2020
Q2
$233K Sell
3,956
-1,389
-26% -$83.1K 0.09% 181
2020
Q1
$298K Buy
5,345
+1,656
+45% +$101K 0.13% 133
2019
Q4
$237K Sell
3,689
-303
-8% -$17.4K 0.09% 186
2019
Q3
$202K Sell
3,992
-551
-12% -$25.9K 0.07% 217
2019
Q2
$206K Buy
+4,543
New +$212K 0.08% 204
2019
Q1
Sell
-12,465
Closed -$648K 249
2018
Q4
$648K Buy
12,465
+807
+7% +$43.4K 0.31% 72
2018
Q3
$724K Buy
11,658
+301
+3% +$17.9K 0.29% 72
2018
Q2
$628K Sell
11,357
-399
-3% -$21.5K 0.29% 73
2018
Q1
$744K Sell
11,756
-323
-3% -$20.8K 0.36% 60
2017
Q4
$740K Sell
12,079
-376
-3% -$23.5K 0.36% 59
2017
Q3
$794K Sell
12,455
-1,108
-8% -$64.7K 0.39% 54
2017
Q2
$756K Buy
+13,563
New +$738K 0.34% 65
2014
Q3
Sell
-2,927
Closed -$142K 225
2014
Q2
$142K Buy
2,927
+342
+13% +$16.9K 0.06% 199
2014
Q1
$134K Hold
2,585
0.06% 202
2013
Q4
$137K Hold
2,585
0.06% 183
2013
Q3
$120K Sell
2,585
-330
-11% -$14.5K 0.06% 173
2013
Q2
$130K Buy
+2,915
New +$127K 0.06% 135

Other funds holding BMY

Partnervest Advisory Services's BMY Position: Q3 2020 in Review

Partnervest Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 7.6% in Q3 2020, buying an estimated $18.1K and bringing the position to 4,257 shares worth $257K. The position accounts for 0.08% of the portfolio, ranked #192.

Partnervest Advisory Services first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. The position peaked at $794K in Q3 2017. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • Partnervest Advisory Services held 4,257 shares of Bristol-Myers Squibb worth $257K as of Q3 2020.
  • Partnervest Advisory Services bought 301 Bristol-Myers Squibb shares in Q3 2020, an estimated $18.1K.
  • Bristol-Myers Squibb made up 0.08% of Partnervest Advisory Services's portfolio in Q3 2020, its #192 holding.
  • Partnervest Advisory Services first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
  • Partnervest Advisory Services's Bristol-Myers Squibb position peaked at $794K in Q3 2017.
  • 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Partnervest Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.